Loss of the second ZnF domain by the G1031X mutation we and others identified in DCM patients (G1009X in mouse) (Fig. 6) or by targeted deletion (Fig. 2) unexpectedly enhanced the repressor activity of RBM20 at least in our reporter assay. Here, RBM20 is linked to familial dilated cardiomyopathy.